Antibodies, Anti-cyclic Citrullinated Peptide (ccp)
Immunology · 21 CFR 866.5775
The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.
Recent MDR events
44 adverse event reports on file
- ELECSYS ANTI-CCPDec 3, 2025MalfunctionRoche Diagnostics1823260-2025-04936
- ELECSYS ANTI-CCPOct 27, 2025MalfunctionRoche Diagnostics1823260-2025-04358
- ELECSYS ANTI-CCPSep 23, 2025MalfunctionRoche Diagnostics1823260-2025-03497
- ELECSYS ANTI-CCPOct 25, 2024MalfunctionRoche Diagnostics1823260-2024-03079
- ELECSYS ANTI-CCPAug 7, 2024MalfunctionRoche Diagnostics1823260-2024-02288
- ELECSYS ANTI-CCPJul 29, 2024MalfunctionRoche Diagnostics1823260-2024-02189
- ELECSYS ANTI-CCPJan 19, 2024MalfunctionRoche Diagnostics1823260-2024-00177
- ELECSYS ANTI-CCPOct 9, 2023MalfunctionRoche Diagnostics1823260-2023-03226
- ELECSYS ANTI-CCPJul 24, 2023MalfunctionRoche Diagnostics1823260-2023-02417
- ELECSYS ANTI-CCPJul 6, 2023MalfunctionRoche Diagnostics1823260-2023-02196
Event type breakdown
Most-reported manufacturers
Recalls
9 recall events for this product code
- Mckesson Medical-Surgical Inc. Corporate OfficeOpen, ClassifiedMay 27, 2025
ABBOTT DIAGNOSTICS ALINITY I ANTI-CCPS REAGENT.
transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.
Z-1853-2025 · View FDA record ↗ - Bio-Rad Laboratories, Inc.Open, ClassifiedApr 12, 2023
BioPlex 2200, Anti-CCP Reagent Pack, REF 665-3250, IVD
Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positives.
Z-1377-2023 · View FDA record ↗ - Bio-Rad Laboratories, Inc.Open, ClassifiedApr 12, 2023
BioPlex 2200, Anti-CCP Calibrator Set, REF 663-3200, IVD
Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positivesBio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positivesBio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positives.There is no performance issue with the calibrator lot# 53727. They are included in the recall only because the calibrators are lot matched to the impacted reagent pack.
Z-1378-2023 · View FDA record ↗ - Roche Diagnostics Operations, Inc.TerminatedAug 23, 2019
Roche Elecsys Anti-CCP Immunoassay
Performance issues with certain lots of the Elecsys Anti-CCP assay on the cobas e 411 analyzer; MODULAR ANALYTICS E 170 module; and cobas e 601, 602, and 801 modules with plasma samples.
Z-2361-2019 · View FDA record ↗ - Roche Diagnostics Operations, Inc.TerminatedAug 23, 2019
Roche Elecsys Anti-CCP Immunoassay
Performance issues with certain lots of the Elecsys Anti-CCP assay on the cobas e 411 analyzer; MODULAR ANALYTICS E 170 module; and cobas e 601, 602, and 801 modules with plasma samples.
Z-2362-2019 · View FDA record ↗ - Euro Diagnostica ABTerminatedAug 23, 2018
Immunoscan CCPlus test kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative and semiquantitative determination of IgG antibodies to Cyclic Citrul
Decreasing performance overtime.
Z-2918-2018 · View FDA record ↗ - Phadia US IncTerminatedFeb 24, 2017
EliA Sample Diluent, Article number, 83-1023-01
Erroneous EliA test results related to problems with liquid level detection and diluent pipetting in Phadia 250 instruments, and deformed bottles. Investigation showed problems with the liquid level detection in diluent bottle batch JJCA resulting in aspiration of no or too low volumes of liquid from the diluent bottle and from the dilution plate.
Z-1253-2017 · View FDA record ↗ - Axis-Shield Diagnostics, Ltd.TerminatedOct 3, 2006
Axis-Shield DIASTAT Anti-CCP test kit, (code FCCP200)
The preservative sodium azide used in the Kit Negative Control (part number FCOM175) was at the wrong concentration - the Kit Negative Control contains 0.2% sodium azide rather than the intended 0.1%.
Z-0003-2007 · View FDA record ↗ - Siemens Healthcare Diagnostics, IncTerminatedUnknown
Atellica IM anti-CCP IgG (aCCP) Assay
Atellica IM anti-CCP IgG (aCCP) Test Definition (TDef) Mitigation Failure-reagent carryover mitigation for the Testosterone II (TSTII) assay is unable to be completed as defined in the aCCP Test Definition (TDef). The issue occurs on an Atellica IM Analyzer and is isolated to TDef Version 1.0. FOR OUS: Atellica IM anti-CCP IgG (aCCP) and Pregnancy-Associated Plasma Protein-A (PAPP-A) Test Definition (TDef) Mitigation Failure
Z-2754-2019 · View FDA record ↗
Registered firms
34 firms currently registered for this product code
Phadia Us Inc.
Portage, MI, US
Euroimmun Medizinische Labordiagnostika Ag
Luebeck Schleswig-Holstein, DE
Abbott Laboratories
Lake Forest, IL, US
Abbott Gmbh
Wiesbaden Hesse, DE
Axis-shield Diagnostics, Ltd.
DUNDEE Scotland, GB
Instrumentation Laboratory Spa
Roncello Lombardy, IT
Immunocentrix Corporation
Canoga Park, CA, US
Inova Diagnostics, Inc.
SAN DIEGO, CA, US
Drg International, Inc.
Springfield, NJ, US
Phadia Ab
UPPSALA, SE
Euroimmun Us Inc.
Mountain Lakes, NJ, US
Svar Life Science Ab
MALMO Skane, SE
Siemens Healthcare Diagnostics Inc.
Tarrytown, NY, US
Bio-rad Laboratories, Inc.
Hercules, CA, US
Bio-rad Laboratories, Inc.
Woodinville, WA, US
Phadia Gmbh
FREIBURG Baden-Wurttemberg, DE
Euroimmun Medizinische Labordiagnostika Ag
Dassow Mecklenburg-Western Pomerania, DE
Phadia Ab
Uppsala, SE
Siemens Healthcare Diagnostics Products Limited
LLANBERIS Wales, GB
Roche Diagnostics Gmbh
MANNHEIM Baden-Wurttemberg, DE
510(k) clearances
21 clearances for this product code
- Axis-Shield Diagnostics LimitedAug 4, 2016
K153551 · ADVIA Centaur Anti-CCP IgG (aCCP) assay including Reagents and Calibrators, Quality Controls and Master Curve Materials.
- Inova Diagnostics, Inc.Sep 21, 2015
K143754 · QUANTA Flash CCP3, QUANTA Flash CCP3 Calibrators, and QUANTA Flash CCP3
- Siemens Healthcare Diagnostics, Inc.Apr 4, 2013
K121576 · IMMULITE 2000 ANTI-CCP IGG ASSAY
- Bio-Rad LaboratoriesOct 26, 2011
K112810 · MULTI-ANALYTE DETECTION SYSTEMS
- Axis-Shield Diagnostics, Ltd.Aug 18, 2011
K110296 · AXIS-SHIELD ANTI-CCP
- Euro-Diagnostica ABDec 1, 2010
K093908 · CCPOINT
- Bio-Rad LaboratoriesAug 24, 2010
K093954 · BIOPLEX 2200 ANTI-CCP KIT ON THE BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM
- Theratest Laboratories, Inc.Mar 5, 2010
K090753 · THERATEST EL-ANTI-CCP/2